PATENT CLAIM ANALYSIS

Application Number: 16084357
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-03
Patent Classification: ["514", "275000"]

Abstract:
The present disclosure relates to solid state forms of Nilotinib fumarate and Nilotinib hydrochloride L-tartaric acid co-crystals, processes for preparation thereof, pharmaceutical compositions thereof, and methods of use thereof.

Claim (Index 1):
A crystalline form of Nilotinib fumarate designated as Form III, characterized by data selected from one or more of the following:\n a. an XRPD pattern having peaks at 5.5, 7.0, 11.0, 13.4 and 15.8 degrees two theta\u00b10.2 degrees two theta; b. an XRPD pattern substantially as depicted in  FIG. 1 ; c. a solid state  13 C NMR spectrum having characteristic peaks at 168.9, 159.1, 135.4 and 114.7\u00b10.2 ppm; d. a solid state  13 C NMR spectrum substantially as depicted in  FIG. 4 ; e. a solid state  13 C NMR spectrum having the following chemical shift absolute differences from a peak at 119.0 ppm\u00b11 ppm of 49.9, 40.1, 16.4 and \u22124.3 ppm\u00b10.1 ppm; f. a solid state  13 C NMR spectrum having chemical shift difference from a peak at 119.0 ppm\u00b11 ppm of 40.1 ppm\u00b10.1 ppm; g. and combinations of these data.

Metadata:
- Claim Count in Document: 16.0
- Percentile: 97.0
- Lexical Diversity: 1.26923
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13806069', '14538939', '12612943', '13989603', '14772566']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7695857709070444
- 35 USC 102 Novelty (BERT): 0.5530899615862053
- Combined Prediction Score: 0.7479361899749605
- Mean Citation Score: 324.5298160000001
- Max Citation Score: 395.75055
- Similarity Product: 352.23112267276343

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test